Literature DB >> 22717515

Conformational changes of apoB-100 in SMase-modified LDL mediate formation of large aggregates at acidic pH.

Mia Sneck1, Su Duy Nguyen, Tero Pihlajamaa, Gebrenegus Yohannes, Marja-Liisa Riekkola, Ross Milne, Petri T Kovanen, Katariina Oörni.   

Abstract

During atherogenesis, the extracellular pH of atherosclerotic lesions decreases. Here, we examined the effect of low, but physiologically plausible pH on aggregation of modified LDL, one of the key processes in atherogenesis. LDL was treated with SMase, and aggregation of the SMase-treated LDL was followed at pH 5.5-7.5. The lower the pH, the more extensive was the aggregation of identically prelipolyzed LDL particles. At pH 5.5-6.0, the aggregates were much larger (size >1 µm) than those formed at neutral pH (100-200 nm). SMase treatment was found to lead to a dramatic decrease in α-helix and concomitant increase in β-sheet structures of apoB-100. Particle aggregation was caused by interactions between newly exposed segments of apoB-100. LDL-derived lipid microemulsions lacking apoB-100 failed to form large aggregates. SMase-induced LDL aggregation could be blocked by lowering the incubation temperature to 15°C, which also inhibited the changes in the conformation of apoB-100, by proteolytic degradation of apoB-100 after SMase-treatment, and by HDL particles. Taken together, sphingomyelin hydrolysis induces exposure of protease-sensitive sites of apoB-100, whose interactions govern subsequent particle aggregation. The supersized LDL aggregates may contribute to the retention of LDL lipids in acidic areas of atherosclerosis-susceptible sites in the arterial intima.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22717515      PMCID: PMC3413224          DOI: 10.1194/jlr.M023218

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  46 in total

Review 1.  Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions.

Authors:  K Oörni; M O Pentikäinen; M Ala-Korpela; P T Kovanen
Journal:  J Lipid Res       Date:  2000-11       Impact factor: 5.922

2.  Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans.

Authors:  Cristina Bancells; Sònia Benítez; Jordi Ordóñez-Llanos; Katariina Öörni; Petri T Kovanen; Ross W Milne; José L Sánchez-Quesada
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

3.  Effects of phospholipase A(2) and its products on structural stability of human LDL: relevance to formation of LDL-derived lipid droplets.

Authors:  Shobini Jayaraman; Donald L Gantz; Olga Gursky
Journal:  J Lipid Res       Date:  2011-01-10       Impact factor: 5.922

4.  Well-defined regions of apolipoprotein B-100 undergo conformational change during its intravascular metabolism.

Authors:  X Wang; R Pease; J Bertinato; R W Milne
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

5.  Thermal transitions in human plasma low density lipoproteins.

Authors:  R J Deckelbaum; G G Shipley; D M Small; R S Lees; P K George
Journal:  Science       Date:  1975-10-24       Impact factor: 47.728

6.  Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix.

Authors:  S Marathe; G Kuriakose; K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

7.  Plasmin-mediated macrophage reversal of low density lipoprotein aggregation.

Authors:  W Y Zhang; I Ishii; H S Kruth
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

8.  LDL binding to lipid emulsion particles: effects of incubation duration, temperature, and addition of plasma subfractions.

Authors:  Nathalie F Chanson; Jean-François Lontie; Annette Gulik; Jacqueline Férézou; Yvon A Carpentier
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

9.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

10.  pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque.

Authors:  Morteza Naghavi; Reji John; Sameh Naguib; Mir Said Siadaty; Roxana Grasu; K C Kurian; W Barry van Winkle; Babs Soller; Silvio Litovsky; Mohammad Madjid; James T Willerson; Ward Casscells
Journal:  Atherosclerosis       Date:  2002-09       Impact factor: 5.162

View more
  11 in total

1.  Kinetic analysis of thermal stability of human low density lipoproteins: a model for LDL fusion in atherogenesis.

Authors:  Mengxiao Lu; Donald L Gantz; Haya Herscovitz; Olga Gursky
Journal:  J Lipid Res       Date:  2012-07-31       Impact factor: 5.922

2.  Acid sphingomyelinase, autophagy, and atherosclerosis.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2014-05       Impact factor: 4.599

3.  Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation.

Authors:  Su Duy Nguyen; Matti Javanainen; Sami Rissanen; Hongxia Zhao; Jenni Huusko; Annukka M Kivelä; Seppo Ylä-Herttuala; Mohamad Navab; Alan M Fogelman; Ilpo Vattulainen; Petri T Kovanen; Katariina Öörni
Journal:  J Lipid Res       Date:  2015-04-10       Impact factor: 5.922

Review 4.  Acidification of the intimal fluid: the perfect storm for atherogenesis.

Authors:  Katariina Öörni; Kristiina Rajamäki; Su Duy Nguyen; Katariina Lähdesmäki; Riia Plihtari; Miriam Lee-Rueckert; Petri T Kovanen
Journal:  J Lipid Res       Date:  2014-11-25       Impact factor: 5.922

5.  Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease.

Authors:  Ana Reis; Alisa Rudnitskaya; Pajaree Chariyavilaskul; Neeraj Dhaun; Vanessa Melville; Jane Goddard; David J Webb; Andrew R Pitt; Corinne M Spickett
Journal:  J Lipid Res       Date:  2014-11-25       Impact factor: 5.922

6.  A correlation between secondary structure and rheological properties of low-density lipoproteins at air/water interfaces.

Authors:  Ziad Khattari
Journal:  J Biol Phys       Date:  2017-06-24       Impact factor: 1.365

7.  Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths.

Authors:  Maija Ruuth; Su Duy Nguyen; Terhi Vihervaara; Mika Hilvo; Teemu D Laajala; Pradeep Kumar Kondadi; Anton Gisterå; Hanna Lähteenmäki; Tiia Kittilä; Jenni Huusko; Matti Uusitupa; Ursula Schwab; Markku J Savolainen; Juha Sinisalo; Marja-Liisa Lokki; Markku S Nieminen; Antti Jula; Markus Perola; Seppo Ylä-Herttula; Lawrence Rudel; Anssi Öörni; Marc Baumann; Amos Baruch; Reijo Laaksonen; Daniel F J Ketelhuth; Tero Aittokallio; Matti Jauhiainen; Reijo Käkelä; Jan Borén; Kevin Jon Williams; Petri T Kovanen; Katariina Öörni
Journal:  Eur Heart J       Date:  2018-07-14       Impact factor: 29.983

Review 8.  Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis.

Authors:  Martina B Lorey; Katariina Öörni; Petri T Kovanen
Journal:  Front Cardiovasc Med       Date:  2022-03-03

Review 9.  ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker.

Authors:  Eva Hurt-Camejo; Germán Camejo
Journal:  J Cardiovasc Dev Dis       Date:  2018-07-01

10.  Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice.

Authors:  Yichuan Wen; Feroz Ahmad; Zahra Mohri; Peter D Weinberg; David S Leake
Journal:  Atherosclerosis       Date:  2019-09-26       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.